Brand Name

Librax

Generic Name
Clidinium
View Brand Information
FDA approval date: September 01, 1966
Classification: Anticholinergic
Form: Capsule

What is Librax (Clidinium)?

Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsule is indicated to control emotional and somatic factors in gastrointestinal disorders. Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsule may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of the irritable bowel syndrome and acute enterocolitis.

Approved To Treat

Top Global Experts

There are no experts for this drug

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

A novel LC-MS/MS method for simultaneous estimation of chlordiazepoxide and clidinium in human plasma and its application to pharmacokinetic assessment.
A novel LC-MS/MS method for simultaneous estimation of chlordiazepoxide and clidinium in human plasma and its application to pharmacokinetic assessment.
Journal: Bioanalysis
Published: May 14, 2025
Fluorescent microsphere-based strip for sensitive and quantitative detection of 3-quinuclidinyl benzilate and clidinium bromide in biological samples.
Fluorescent microsphere-based strip for sensitive and quantitative detection of 3-quinuclidinyl benzilate and clidinium bromide in biological samples.
Journal: Analytical methods : advancing methods and applications
Published: May 07, 2025
Dopaminergic Drugs and Valproate-associated Refractory Hyponatremia Over Levosulpiride-induced Parkinsonism in an Elderly Female Patient When Deprescribing was the Only Therapy.
Dopaminergic Drugs and Valproate-associated Refractory Hyponatremia Over Levosulpiride-induced Parkinsonism in an Elderly Female Patient When Deprescribing was the Only Therapy.
Journal: Current drug safety
Published: December 08, 2023
View All Latest Advances